Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials

BACKGROUND: In multiple clinical studies, teduglutide reduced parenteral support (PS) with a consistent safety profile in adults with short bowel syndrome–associated intestinal failure (SBS–IF). The objective of this study was to assess adverse events (AEs) from a pooled data set. METHODS: Safety da...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Ulrich-Frank, Iyer, Kishore R., Jeppesen, Palle B., Kunecki, Marek, Pironi, Loris, Schneider, Stéphane M., Seidner, Douglas L., Lee, Hak-Myung, Caminis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171995/
https://www.ncbi.nlm.nih.gov/pubmed/32341691
http://dx.doi.org/10.1177/1756284820905766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171995/
https://www.ncbi.nlm.nih.gov/pubmed/32341691
http://dx.doi.org/10.1177/1756284820905766

Ejemplares similares